Low-Level Laser Therapy Treatment of Lung Inflammation in COVID-19 Patients
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Covid19
- Sponsor
- Ward Photonics LLC
- Locations
- 1
- Primary Endpoint
- Inflammation of the lungs - CRP
- Status
- Withdrawn
- Last Updated
- 3 years ago
Overview
Brief Summary
To determine if a reduction of pneumonic inflammation occurs after treatment with Low-Level Laser Therapy (LLLT) applying red-light technology in the respiratory system of COVID-19 patients suffering from acute viral pneumonia.
Detailed Description
This clinical trial is a blinded before and after comparison of the effect on patients treated with a red-light LLLT therapy for acute lung inflammation as a result of COVID-19 infection. Patients are enrolled to undergo LLLT therapy in addition to all standard ongoing therapies for COVID-19. Outcomes for patients receiving LLLT in addition to their standard care (the treatment group) are compared to the group receiving only standard therapy for COVID-19 (control group). Effects of LLLT treatment are measured immediately following treatment, and outcome measurements are compared to the pre-treatment baseline.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participant is diagnosed with COVID-
- •Study participant is 18 years of age or older.
- •Patient exhibiting moderate-to-acute respiratory distress.
Exclusion Criteria
- •Photosensitive condition or medication.
- •Active chemotherapy treatment or other cancer treatment.
- •Autoimmune Disorder.
- •Pregnant, possibly pregnant or planning pregnancy prior to the end of study participation.
- •Developmental disability or cognitive impairment that, in the opinion of the investigator, would preclude adequate comprehension of the informed consent form and/or ability to record the necessary study measurements.
Outcomes
Primary Outcomes
Inflammation of the lungs - CRP
Time Frame: 10 days
Change in inflammation of the lungs as measured by C-Reactive Protein (CRP) Test
Inflammation of the lungs - IL6
Time Frame: 10 days
Change in inflammation of the lungs as measured by IL-6 Levels
Inflammation of the lungs - O2
Time Frame: 10 days
Change in inflammation of the lungs as measured by O2 saturation levels